Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Mosedipimod by Enzychem Lifesciences for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Mosedipimod is under clinical development by Enzychem Lifesciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
Mosedipimod by Enzychem Lifesciences for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Mosedipimod is under clinical development by Enzychem Lifesciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute...
AVI-4015 by Enzychem Lifesciences for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
AVI-4015 is under clinical development by Enzychem Lifesciences and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to...